Post-market validation of a further five serological assays for COVID-19 – updated report

The Doherty Institute has evaluated 27 serology-based point of care tests.

The evaluation is part of a review of these tests by the Therapeutic Goods Administration (TGA).

These findings will inform the need for TGA to undertake any post-market action.

This could include changes to the instructions for use to include more information about the limitations of the tests.

Further information is on the TGA’s website, post-market evaluation of serology-based point of care tests.